Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis

Menopause

Volumn 21, Issue 10, 2014, Pages 1075-1081

  Davis, Susan R ^a   Panjari, Mary ^a   Robinson, Penelope J ^a   Fradkin, Pamela ^a   Bell, Robin J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Breast cancer; Menopause; Sexual function

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADJUVANT CHEMOTHERAPY; ADRENERGIC SYSTEM; AGED; AUSTRALIA; BREAST TUMOR; CHEMISTRY; COHORT ANALYSIS; FEMALE; FOLLOW UP; HOT FLASHES; HUMAN; MENOPAUSE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCTIVE HEALTH; SURVIVOR;

AGED; AUSTRALIA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCTIVE HEALTH; SURVIVORS; VASOMOTOR SYSTEM;

EID: 84914101690     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0000000000000219     Document Type: Article

References (20)

1. Gupta P, Sturdee DW, Palin SL, et al. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 2006;9:49-58.
2. Marino JL, Saunders CM, Emery LI, Green H, Doherty DA, Hickey M. Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history. Menopause 2014;21:267-274.
3. Conde DM, Pinto-Neto AM, Cabello C, Sa DS, Costa-Paiva L, Martinez EZ. Menopause symptoms and quality of life in women aged 45 to 65 years with and without breast cancer. Menopause 2005;12:436-443.
4. Schultz PN, Klein MJ, Beck ML, Stava C, Sellin RV. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in longterm survivors. J Clin Nurs 2005;14:204-211.
5. Biglia N, Cozzarella M, Cacciari F, et al. Menopause after breast cancer: a survey on breast cancer survivors. Maturitas 2003;45:29.
6. Crandall C, Petersen L, Ganz PA, Greendale GA. Association of breast cancer and its therapy with menopause-related symptoms. Menopause 2004;11:519-530.
7. Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 2002;23:501-509.
8. Bell RJ, Lijovic M, La China M, et al. Psychological well-being in a cohort of women with invasive breast cancer nearly 2 years after diagnosis. Support Care Cancer 2010;18:921-929.
9. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847-3853.
10. Lijovic M, Davis SR, Fradkin P, et al. Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer. BMC Cancer 2008;8:126-130.
11. Bell RJ, Lijovic M, Fradkin P, Davis SR. A pragmatic approach to the classification of menopausal status for community-based research. Menopause 2008;15:978-983.
12. Hilditch J, Lewis J, Peter A, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996;24:161-175.
13. Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the Menopause-Specific Quality of Life Questionnaire and development of a modified version, MENQOL-Intervention questionnaire. Maturitas 2005;50:209-221.
14. Botlero R, Davis SR, Urquhart DM, Shortreed S, Bell RJ. Age-specific prevalence of, and factors associated with, different types of urinary incontinence in community-dwelling Australian women assessed with a validated questionnaire. Maturitas 2009;62:134-139.
15. Shapiro CL, Manola J, Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 2001;19:3306.
16. Carpenter JS, Johnson D, Wagner L, Andrykowski M. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 2002;29:E16-E25.
17. Davis SR, Davison SL, Wilson S, Shepherd J, Lawton B. Intranasal versus transdermal matrix oestrogen replacement in Australasian women. Maturitas 2005;51:163-171.
18. La Croix AZ, Freeman EW, Larson J, et al. Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial. Maturitas 2012;73:361-368.
19. Loprinzi CL, Sloan J, Stearns V, et al. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 2009;27:2831-2837.
20. Panjari M, Bell RJ, Davis SR. Sexual function after breast cancer. J Sex Med 2011;8:294-302.